Read our newsletter for coverage of events, news, research highlights, grants, awards, and more in the Populations Sciences Research Program at MSK.
- August 2018
- November 2017
- June 2017
- November 2016
- September 2016
- May 2016
- March 2016
- January 2016
- November 2015
- September 2015
Experts discuss challenges in triple-negative breast cancer; predicting late effects of cancer treatment; germline testing approved for MSK patients
Skin cancer research at MSK addresses risk, behavior and survivorship; direct-to-consumer genetic carrier test authorized by FDA.
Public health and clinical experts address HPV and prevention, and Q&A with Deborah Korenstein.
Expanding SOAR studies outside of Manhattan, studying e-cigarette use, and an epidemiology forum planned for February 2015.
MSK Transdisciplinary Population Science awards announced, new Survivorship Center established, and a discussion about universal screening for BRCA1 and BRCA2.
Integrative Medicine Service studies complementary therapies, gene mutation associated with rare ovarian cancer, and a Q&A with surgeon Behfar Ehdaie.
Five decades of tobacco research, control and public awareness, ASCO celebrates its 50th anniversary, and a Q&A with physiologist Lee Jones.
Surveillance, Epidemiology, and End Results Program celebrates its 40th year, CCNY-MSKCC Partnership grant is renewed, Channel and Goldstein Grants awarded to Memorial Sloan Kettering investigators, and US Preventive Services Task Force finalized its recommendations for lung cancer screening.
Memorial Sloan Kettering protects research resources and plans for the future, meeting address health disparities and needs in South Asian immigrant communities, and Institute of Medicine declares cancer care delivery system “in crisis”.
Memorial Sloan Kettering symposium addresses challenges in genetic epidemiology, institutional biospecimen protocol amended to address new tests and incidental findings, and a Q&A with psychologist Jada Hamilton.
Genomic analysis reveals endometrial cancer subtypes, new research council established for minimal risk studies, and a Q&A with health services researcher Yvonne Bombard.
Federal budget cuts take effect, comments and advice from Colin Begg on the “grant game,” and ASCO issues a statement on survivorship care.
Memorial Sloan Kettering group studies needs of immigrant and underserved communities in New York City, Supreme Court will decide whether human genes can be patented, and new funding opportunities in outcomes research.
Guidelines discourage routine prostate cancer screening, SOAR Investigators successful despite challenging funding climate, and a Q&A with physician-scientist Sigrid Carlsson.
A welcome message from Colin Begg, new guidelines for lung cancer screening, and SOAR faculty present at ASCO annual meetings.